Literature DB >> 26893056

Vanillin restrains non-enzymatic glycation and aggregation of albumin by chemical chaperone like function.

Saurabh Awasthi1, N T Saraswathi2.   

Abstract

Vanillin a major component of vanilla bean extract is commonly used a natural flavoring agent. Glycation is known to induce aggregation and fibrillation of globular proteins such as albumin, hemoglobin. Here we report the inhibitory potential of vanillin toward early and advanced glycation modification and amyloid like aggregation of albumin based on the determination of both early and advanced glycation and conformational changes in albumin using circular dichroism. Inhibition of aggregation and fibrillation of albumin was determined based on amyloid specific dyes i.e., Congo red and Thioflavin T and microscopic imaging. It was evident that vanillin restrains glycation of albumin and exhibits protective effect toward its native conformation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aggregation; Glycation; Vanillin

Mesh:

Substances:

Year:  2016        PMID: 26893056     DOI: 10.1016/j.ijbiomac.2016.02.041

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  4 in total

1.  Peppermint extract inhibits protein aggregation.

Authors:  Phanindra Babu Kasi; Kinga Molnár; Lajos László; Márta Kotormán
Journal:  Biol Futur       Date:  2021-05-04

2.  Fruit juices are effective anti-amyloidogenic agents.

Authors:  Márta Kotormán; Dóra Romhányi; Bence Alpek; Orsolya Papp; Katalin Márton
Journal:  Biol Futur       Date:  2021-02-05

3.  Coffee extracts effectively inhibit the formation of α-chymotrypsin amyloid-like fibrils in aqueous ethanol in vitro.

Authors:  Márta Kotormán; Vanda Andrea Bedő
Journal:  Biol Futur       Date:  2020-05-13

4.  Vanillin Affects Amyloid Aggregation and Non-Enzymatic Glycation in Human Insulin.

Authors:  Clara Iannuzzi; Margherita Borriello; Gaetano Irace; Marcella Cammarota; Antimo Di Maro; Ivana Sirangelo
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.